Phase I Trials
Synexus in South Africa has a 36 bed Phase I unit located at its Pretoria site. This unit, which has now been running for more than 5 years, has undertaken more than 25 Phase I/BE/BA and Phase IIa studies.
These trials include:
- Vaccines
- Infectious diseases
- HIV
For more information on Phase I trials please contact Synexus in South Africa:
Sanet Aspinall/Mark Shardelow:
By phone: +27 12 803 7733
By email: sanet.aspinall@synexus-sa.co.za or mark.shardelow@addclinresearch.co.za
Click here to return to Phases and Study Types
Have more questions? Contact us for more information


